Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

Here's What Key Metrics Tell Us About Air Products and Chemicals (APD) Q2 Earnings

Although the revenue and EPS for Air Products and Chemicals (APD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

APDNegative Net Change

Zacks Equity Research

Why Exponent (EXPO) Might be Well Poised for a Surge

Exponent (EXPO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

EXPONegative Net Change

Zacks Equity Research

Surging Earnings Estimates Signal Upside for Trustmark (TRMK) Stock

Trustmark (TRMK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

TRMKNegative Net Change

Zacks Equity Research

Can Alphabet (GOOG) Run Higher on Rising Earnings Estimates?

Alphabet (GOOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GOOGNegative Net Change

Zacks Equity Research

Why Hasbro (HAS) Might be Well Poised for a Surge

Hasbro (HAS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

HASNegative Net Change

Zacks Equity Research

All You Need to Know About Nayax (NYAX) Rating Upgrade to Buy

Nayax (NYAX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NYAXPositive Net Change

Zacks Equity Research

Arch Capital (ACGL) Upgraded to Buy: Here's What You Should Know

Arch Capital (ACGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ACGLPositive Net Change

Zacks Equity Research

Trustmark (TRMK) Upgraded to Strong Buy: Here's What You Should Know

Trustmark (TRMK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TRMKNegative Net Change

Zacks Equity Research

What Makes Gray Television (GTN) a New Buy Stock

Gray Television (GTN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GTNNegative Net Change

Zacks Equity Research

IGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock?

IGM Biosciences (IGMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

IGMSPositive Net Change

Zacks Equity Research

What Makes B2Gold (BTG) a New Buy Stock

B2Gold (BTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BTGNegative Net Change

Zacks Equity Research

What Makes Ventyx Biosciences (VTYX) a New Buy Stock

Ventyx Biosciences (VTYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VTYXNegative Net Change

Zacks Equity Research

All You Need to Know About Royal Caribbean (RCL) Rating Upgrade to Strong Buy

Royal Caribbean (RCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

RCLNegative Net Change

Zacks Equity Research

HUTCHMED (HCM) Upgraded to Buy: Here's What You Should Know

HUTCHMED (HCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HCMNegative Net Change

Zacks Equity Research

Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why

Rocket Pharmaceuticals (RCKT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

RCKTPositive Net Change

Zacks Equity Research

First Financial Corp. (THFF) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for First Financial Corp. (THFF) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

THFFNegative Net Change

Zacks Equity Research

Compared to Estimates, Restaurant Brands (QSR) Q1 Earnings: A Look at Key Metrics

The headline numbers for Restaurant Brands (QSR) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

QSRPositive Net Change

Zacks Equity Research

Compared to Estimates, Rithm (RITM) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Rithm (RITM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

RITMPositive Net Change

Zacks Equity Research

Middlefield Banc (MBCN) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Middlefield Banc (MBCN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

MBCNNegative Net Change

Zacks Equity Research

Here's What Key Metrics Tell Us About NexPoint Residential Trust Inc. (NXRT) Q1 Earnings

Although the revenue and EPS for NexPoint Residential Trust Inc. (NXRT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

NXRTPositive Net Change

Zacks Equity Research

Melco (MLCO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Melco (MLCO) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

MLCOPositive Net Change

Zacks Equity Research

Penske (PAG) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Penske (PAG) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

PAGNegative Net Change

Zacks Equity Research

Taylor Morrison (TMHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Taylor Morrison (TMHC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

TMHCNegative Net Change

Zacks Equity Research

Sirius XM (SIRI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Sirius XM (SIRI) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

SIRINegative Net Change

Zacks Equity Research

Compared to Estimates, Camden National (CAC) Q1 Earnings: A Look at Key Metrics

The headline numbers for Camden National (CAC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CACPositive Net Change